HPLC and MS in Peptide QC: A Buyer’s Checklist

Procurement teams see HPLC purity % on almost every peptide conversation—and MS on some. The mistake is treating “more letters on the COA” as a quality scoreboard. HPLC and mass spectrometry answer different questions. Your job is to request the combination that matches your specification, then read the lot document without turning it into a medical or marketing claim.

This checklist is for B2B buyers (export procurement, QC contacts, OEM brand ops) evaluating analytical packs on catalog or custom peptides. It is not a clinical methods manual and not guidance for personal use or dosing.

Process home: Quality & documentation. Sample files: COA Vault. Companion on document limits: What a peptide COA proves.

---

What HPLC is used for in peptide release

In peptide lot release, HPLC is commonly used to support purity (and related-substances) results against an agreed method. Buyers should care about more than the headline percentage:

• Is the method identified (code / description) so results are comparable across lots?
• Is the result tied to a lot / batch ID?
• Does your RFQ state the target purity band and format (lyophilized vial vs powder)?

Limit: an HPLC purity number is not, by itself, a complete identity story in every workflow. Identity may rely on additional methods defined in the specification. If the COA only shows a bare % with no method or lot context, treat it as incomplete for release diligence.

---

What MS adds (when the specification requires it)

Mass spectrometry is often used for identity / mass confirmation when the agreed spec calls for it. Practical buyer rules:

• Ask for MS explicitly on the RFQ when your internal spec or destination audit expects it.
• Do not assume every cosmetic or catalog vial automatically needs a full research-grade MS suite—over-specifying can add cost and lead time without changing your real use case.
• When MS is required, confirm it appears as a result on the lot COA, not as a vague website claim.

Custom sequences should list purity targets, modifications, and analytical expectations up front via Custom peptide synthesis and Quote Cart.

---

Buyer checklist before RFQ / PO

Use this sequence on every new SKU family or new supplier:

1. State target purity, quantity, and format on the RFQ (and destination country if docs differ).
2. Ask which methods will appear on the lot COA (HPLC; MS if required; others if your spec needs them).
3. Request a sample vault COA for an analogous SKU to inspect document shape (COA Vault).
4. Match the production lot COA to the shipment packing list—not a generic marketing PDF.
5. Escalate deviations to whoever owns analytical release (manufacturer ownership matters—see verify manufacturer vs reseller).

If a supplier cannot name methods or ownership, that is a procurement signal—not a negotiation nicety.

---

How to read results without over-claiming

Purity is lot-specific. A COA does not authorize therapeutic claims, consumer dosing narratives, or performance merchandising. Our boundaries are on Compliance. For proves / doesn’t detail, read What a peptide COA proves.

---

Peptisova default analytical spine

• HPLC as the default purity spine for catalog and OEM release documentation.
• MS where the specification requires confirmation.
• Honest cert posture: no badge theater without evidence; prefer downloadable lot docs over empty walls (Quality).
• Public samples for diligence UX in the COA Vault; production lots attach to commercial shipments.

Need method questions on a custom or bulk program? Use Quote Cart with your spec attached.

---

---

RFQ language you can copy

Paste and adapt into Quote Cart or email:

> Please quote against HPLC purity target of ___% for sequence/SKU ___, format ___, quantity ___. Lot COA should identify the HPLC method. MS confirmation: [required / not required] per our specification. Provide a sample COA for an analogous catalog SKU before PO, and the matching production lot COA with shipment.

That single paragraph prevents half of the “we thought MS was included” disputes. Pair it with Custom peptide synthesis when the line is free-sequence work, or with catalog SKUs when you are buying Track A material from Products.

Also decide who in your company signs off on analytical exceptions. If only sales reads the COA, deviations become commercial arguments instead of quality decisions—another reason to separate manufacturer ownership questions (verify hub) from brochure trust.

Next step

Review Quality & documentation, download a sample from the COA Vault, then put purity targets and required methods into your next RFQ.

Peptisova supports B2B peptide manufacturing, catalog, and OEM documentation. We do not provide dosing guidance or weight-loss / Melanotan retail programs.